A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

257

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Major Depressive DisorderPsychotic Disorders
Interventions
DRUG

Mifepristone

daily for 7 days

DRUG

matching placebo

daily for 7 days

Trial Locations (23)

11004

Zucker Hillside Hospital, Glen Oaks

11559

Neurobehavioral Research Company, Lawrence

19149

CNS Research Institute, Philadelphia

23229

International Clinical Research Associates, Richmond

30308

Atlanta Center for Medical Research, Atlanta

32257

University of Florida Clinical Trials, Jacksonville

33064

Quantum Laboratories/Memory Disorder Center, Pompano Beach

44124

Rakesh Ranjan, MD and Associates, Inc, Lyndhurst

45408

Midwest Clinical Research Center, Dayton

46143

Valle Vista Health System, Greenwood

48334

Psychopharmacology Research, Farmington Hills

60523

American Medical Research, Inc., Oak Brook

73101

IPS Research Company, Oklahoma City

76309

Grayline Clinical Drug Trials, Wichita Falls

77401

Claghorn-Lesem Research Clinic, Bellaire

89102

Robert Horne, MD, Las Vegas

90660

CNRI-LA, Pico Rivera

92126

Cnri, Llc, San Diego

92506

Behavioral Health 2000, LLC, Riverside

98004

Northwest Clinical Research Center, Bellevue

08021

CNS Research Institute, Clementon

07101

NMDNJ, Newark

08755

Bio Behavioral Health, Toms River

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY